Cargando…

Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth

Human embryonic stem cells (hESCs) are self-renewing pluripotent cells that can differentiate into specialized cells and hold great promise as models for human development and disease studies, cell-replacement therapies, drug discovery and in vitro cytotoxicity tests. The culture and differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Romorini, Leonardo, Riva, Diego Ariel, Blüguermann, Carolina, Videla Richardson, Guillermo Agustin, Scassa, Maria Elida, Sevlever, Gustavo Emilio, Miriuka, Santiago Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728093/
https://www.ncbi.nlm.nih.gov/pubmed/23936178
http://dx.doi.org/10.1371/journal.pone.0070267
_version_ 1782278804145700864
author Romorini, Leonardo
Riva, Diego Ariel
Blüguermann, Carolina
Videla Richardson, Guillermo Agustin
Scassa, Maria Elida
Sevlever, Gustavo Emilio
Miriuka, Santiago Gabriel
author_facet Romorini, Leonardo
Riva, Diego Ariel
Blüguermann, Carolina
Videla Richardson, Guillermo Agustin
Scassa, Maria Elida
Sevlever, Gustavo Emilio
Miriuka, Santiago Gabriel
author_sort Romorini, Leonardo
collection PubMed
description Human embryonic stem cells (hESCs) are self-renewing pluripotent cells that can differentiate into specialized cells and hold great promise as models for human development and disease studies, cell-replacement therapies, drug discovery and in vitro cytotoxicity tests. The culture and differentiation of these cells are both complex and expensive, so it is essential to extreme aseptic conditions. hESCs are susceptible to Mycoplasma sp. infection, which is hard to detect and alters stem cell-associated properties. The purpose of this work was to evaluate the efficacy and cytotoxic effect of Plasmocin(TM) and ciprofloxacin (specific antibiotics used for Mycoplasma sp. eradication) on hESCs. Mycoplasma sp. infected HUES-5 884 (H5 884, stable hESCs H5-brachyury promoter-GFP line) cells were effectively cured with a 14 days Plasmocin(TM) 25 µg/ml treatment (curative treatment) while maintaining stemness characteristic features. Furthermore, cured H5 884 cells exhibit the same karyotype as the parental H5 line and expressed GFP, through up-regulation of brachyury promoter, at day 4 of differentiation onset. Moreover, H5 cells treated with ciprofloxacin 10 µg/ml for 14 days (mimic of curative treatment) and H5 and WA09 (H9) hESCs treated with Plasmocin(TM) 5 µg/ml (prophylactic treatment) for 5 passages retained hESCs features, as judged by the expression of stemness-related genes (TRA1-60, TRA1-81, SSEA-4, Oct-4, Nanog) at mRNA and protein levels. In addition, the presence of specific markers of the three germ layers (brachyury, Nkx2.5 and cTnT: mesoderm; AFP: endoderm; nestin and Pax-6: ectoderm) was verified in in vitro differentiated antibiotic-treated hESCs. In conclusion, we found that Plasmocin(TM) and ciprofloxacin do not affect hESCs stemness and pluripotency nor cell viability. However, curative treatments slightly diminished cell growth rate. This cytotoxic effect was reversible as cells regained normal growth rate upon antibiotic withdrawal.
format Online
Article
Text
id pubmed-3728093
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37280932013-08-09 Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth Romorini, Leonardo Riva, Diego Ariel Blüguermann, Carolina Videla Richardson, Guillermo Agustin Scassa, Maria Elida Sevlever, Gustavo Emilio Miriuka, Santiago Gabriel PLoS One Research Article Human embryonic stem cells (hESCs) are self-renewing pluripotent cells that can differentiate into specialized cells and hold great promise as models for human development and disease studies, cell-replacement therapies, drug discovery and in vitro cytotoxicity tests. The culture and differentiation of these cells are both complex and expensive, so it is essential to extreme aseptic conditions. hESCs are susceptible to Mycoplasma sp. infection, which is hard to detect and alters stem cell-associated properties. The purpose of this work was to evaluate the efficacy and cytotoxic effect of Plasmocin(TM) and ciprofloxacin (specific antibiotics used for Mycoplasma sp. eradication) on hESCs. Mycoplasma sp. infected HUES-5 884 (H5 884, stable hESCs H5-brachyury promoter-GFP line) cells were effectively cured with a 14 days Plasmocin(TM) 25 µg/ml treatment (curative treatment) while maintaining stemness characteristic features. Furthermore, cured H5 884 cells exhibit the same karyotype as the parental H5 line and expressed GFP, through up-regulation of brachyury promoter, at day 4 of differentiation onset. Moreover, H5 cells treated with ciprofloxacin 10 µg/ml for 14 days (mimic of curative treatment) and H5 and WA09 (H9) hESCs treated with Plasmocin(TM) 5 µg/ml (prophylactic treatment) for 5 passages retained hESCs features, as judged by the expression of stemness-related genes (TRA1-60, TRA1-81, SSEA-4, Oct-4, Nanog) at mRNA and protein levels. In addition, the presence of specific markers of the three germ layers (brachyury, Nkx2.5 and cTnT: mesoderm; AFP: endoderm; nestin and Pax-6: ectoderm) was verified in in vitro differentiated antibiotic-treated hESCs. In conclusion, we found that Plasmocin(TM) and ciprofloxacin do not affect hESCs stemness and pluripotency nor cell viability. However, curative treatments slightly diminished cell growth rate. This cytotoxic effect was reversible as cells regained normal growth rate upon antibiotic withdrawal. Public Library of Science 2013-07-30 /pmc/articles/PMC3728093/ /pubmed/23936178 http://dx.doi.org/10.1371/journal.pone.0070267 Text en © 2013 Romorini et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Romorini, Leonardo
Riva, Diego Ariel
Blüguermann, Carolina
Videla Richardson, Guillermo Agustin
Scassa, Maria Elida
Sevlever, Gustavo Emilio
Miriuka, Santiago Gabriel
Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title_full Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title_fullStr Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title_full_unstemmed Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title_short Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth
title_sort effect of antibiotics against mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728093/
https://www.ncbi.nlm.nih.gov/pubmed/23936178
http://dx.doi.org/10.1371/journal.pone.0070267
work_keys_str_mv AT romorinileonardo effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT rivadiegoariel effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT bluguermanncarolina effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT videlarichardsonguillermoagustin effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT scassamariaelida effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT sevlevergustavoemilio effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth
AT miriukasantiagogabriel effectofantibioticsagainstmycoplasmasponhumanembryonicstemcellsundifferentiatedstatuspluripotencycellviabilityandgrowth